Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

T wave alternans for ventricular arrhythmia risk stratification.

Ahmed F Osman1, Michael R Gold

  • 1Departments of Medicine and Physiology, University of Maryland, Baltimore, Maryland 21201, USA.

Current Opinion in Cardiology
|January 16, 2002
PubMed
Summary

T wave alternans (TWA) effectively identifies patients at risk for sudden cardiac death by measuring arrhythmia vulnerability. Further research is needed to clarify TWA's role in guiding clinical therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insulin receptor trafficking and interactions in muscle cells.

Journal of the Endocrine Society·2026
Same author

Normalized QRS Duration by LV Dimension: Eliminating Sex-Specific Differences and Predicting Cardiac Resynchronization Therapy Outcomes.

JACC. Clinical electrophysiology·2026
Same author

Acute Thrombosis During Atrial Leadless Pacemaker Implantation.

JACC. Case reports·2025
Same author

The tropomyosin 3.1/3.2 inhibitor ATM-3507 alters B-cell actin dynamics and impairs the growth and motility of diffuse large B-cell lymphoma cell lines.

Frontiers in immunology·2025
Same author

Validation of an automated premature ventricular contraction mapping algorithm.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2025
Same author

Cost-effectiveness of apixaban vs. aspirin for the reduction of thrombo-embolism in high-risk patients with device-detected atrial fibrillation: insights from the ARTESiA trial.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2025

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Diagnostics

Background:

  • Sudden cardiac death (SCD) poses a significant public health challenge.
  • Identifying high-risk individuals is crucial for effective prevention strategies.
  • T wave alternans (TWA) is a recognized biomarker for arrhythmia vulnerability.

Purpose of the Study:

  • To evaluate the predictive value of T wave alternans (TWA) in identifying patients at risk for sudden cardiac death.
  • To explore the application of TWA across diverse patient populations with varying cardiac conditions.

Main Methods:

  • T wave alternans (TWA) measurement, a heart-rate-dependent electrophysiological test.
  • Optimal predictive accuracy observed at heart rates of 100-120 bpm, typically induced by exercise or atrial pacing.

Related Experiment Videos

  • Application of TWA testing in patient cohorts including coronary artery disease, nonischemic cardiomyopathy, and heart failure.

    • Main Results:

    • TWA demonstrates predictive capability for inducible ventricular tachycardia via programmed stimulation.
    • TWA has shown efficacy in predicting spontaneous arrhythmic events.
    • The test has been successfully applied to various patient groups, indicating broad clinical relevance.

    Conclusions:

    • T wave alternans (TWA) is a promising tool for assessing sudden cardiac death risk.
    • While TWA shows significant predictive power, its precise role in guiding clinical treatment requires further investigation and validation.